We have examined bacterial determinants that influence 13-lactam activity in HaemophUilus influenzae cells cultivated in a system that reproduces in vivo growth conditions. Bacteria grown in diffusion chambers were recovered from the peritoneal cavities of rats, and their cell properties were compared with those of bacteria grown in broth cultures by various tests performed in vitro. The rate of peptidoglycan synthesis was measured as the incorporation of [14C]alanine into cell wall material in the presence of chloramphenicol. The total incorporation of [14Cjalanine into peptidoglycan was markedly increased in cells grown in rats prior to the assay but was efficiently reduced by the 13-lactams. The extent of cross-linking was lower in the peptidoglycan of in vivo-grown bacteria, as estimated by sodium dodecyl sulfate-to trichloroacetic acid-insoluble radioactive cell wall material ratios. A whole-cell labeling assay with 1211-penicillin was used to characterize the penicillin-binding proteins (PBPs). Four PBPs showed a striking reduction in the binding of the labeled penicillin in cells grown in rats. Such changes resembled the PBP alterations seen in 13-lactamase-negative clinical strains that were resistant to the 13-lactams. Although ampicillln and moxalactam showed delayed inhibitory activities in vitro for cells collected from rats, cells recovered from P-lactam-treated rats showed evidence of antibiotic effectiveness (binding of the 1-lactams to PBPs in vivo and altered morphology), and the killing of cells exposed to antibiotics in broth or in peritoneal fluid was equally good. Finally, the frequencies of spontaneous resistance or tolerance to ampicillin or moxalactam were estimated, and there was no significant difference for in vitro-or in vivo-grown cells. These data demonstrated that the cultivation of H. influenzae in animals created changes in PBPs and the overall peptidoglycan metabolism. Such alterations did not impair the bactericidal activities of the 13-lactams, although they resulted in delayed bacterial inhibition, a phenomenon that may have important consequences in antibiotherapy.
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,B-Lactam antibiotics act on bacterial cell wall peptidoglycan synthesis through the inhibition of enzymes termed penicillin-binding proteins (PBPs) (34) . Some of these antibiotics are currently used for the treatment of serious infections caused by Haemophilus influenzae. In vitro susceptibility tests are used to determine the antibacterial activities of ,B-lactams and to provide the information necessary for the development of new drugs. However, there is now considerable evidence that growth conditions and the physiological state of bacteria influence dramatically the susceptibilities of cells to 1-lactam antibiotics (9) , and there is a need to predict more accurately how bacteria will behave during antibiotherapy (15) .
For example, it is known that slow-growing or nongrowing Escherichia coli cells are more resistant to the bactericidal action of 13-lactams (30) , a phenomenon that is called phenotypic tolerance and that correlates with changes in the rate of synthesis of peptidoglycan and its composition (24, 31) as well as with a decreased sensitivity of murein to autolysins (32) . Physiological processes in E. coli that induce phenotypic tolerance include the stringent response (12) and the induction of heat shock proteins (25) . These cellular processes are fully reversible and are among the survival strategies for the growth of bacteria in their natural environment. However, it is conceivable that under antibiotic pressure, mutations in physiological systems may arise and cause permanent clinical resistance or genetic tolerance to ,-lactams.
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Although several in vitro studies have been useful in determining the effect of growth conditions on the susceptibilities of bacteria to antibiotics, there is a need for an in vivo cultivation system that allows the recovery of large quantities of cells after growth in a natural environment for biochemical and physiological analyses and for studies of the possible origin and molecular basis of some mechanisms of clinical resistance. In the present study, we used intraperitoneal diffusion chambers implanted in rats for the cultivation of H. influenzae and studied some bacterial determinants that influence susceptibilities to P-lactam antibiotics. We found important modifications in the overall peptidoglycan metabolism and in PBPs and hypothesized on the origin of clinical P-lactam resistance due to alterations of the cellular targets of these drugs.
MATERIALS AND METHODS
Bacterial strains. The ,B-lactam-susceptible laboratory strain H. influenzae Rd and two 3-lactam-resistant isogenic strains (Rd/A-145 and Rd/E-170) obtained by transformation with DNA isolated from ,-lactamase-negative, ampicillinresistant isolates collected during a study in Canada (29) were used in this study. Ampicillin, penicillin G, and moxalactam had MICs of 0.25, 0.125, and 0.025 ,ug/ml for strain Rd, 2, 4, and 0.4 p,g/ml for strain Rd/A-145, and 2, 1, and 0.4 ±g/ml for strain Rd/E-170, respectively (5).
In vitro growth conditions. Bacteria were grown in brain heart infusion broth (Difco Laboratories, Detroit, Mich.) supplemented (sBHI) with (14) . PBP proifies were visualized by autoradiography after exposure of the dried gels to Kodak X-Omat film for 1 to 7 days at -20TC.
In PBP competition experiments, the cells were prelabeled with various concentrations of a competing 3-lactam for 10 min prior to the addition of 125I-penicillin V. The concentration of the competing 1-lactam needed to block 50% of the subsequent binding of the radiolabeled penicillin to a particular PBP was determined by scanning the PBP profiles obtained on the X-ray film with a Bio-Rad model 620 video densitometer.
Electron microscopy. The procedure used for the preparation of samples for electron microscopy was described before (2, 10 Fig. 1 , the radioactivity was found in the TCA-soluble fraction after specific digestion of peptidoglycan by lysozyme. In addition, the incorporation of [14C]alanine into H. influenzae peptidoglycan was specifically inhibited by increasing amounts of penicillin G in the assay (Fig. 2) .
Measurement of the rate of peptidoglycan synthesis. The rates of peptidoglycan synthesis in H. influenzae cells that were cultivated in vitro and in diffusion chambers implanted in rats were measured in M-IV medium (Fig. 3) (Fig. 4) . The data showed that there was equivalent uptake of [14C]alanine by cells that were grown either in vitro or in rats, meaning that the apparent increase in the rate of peptidoglycan synthesis observed in in vivo-grown H. influenzae cells (Fig. 3) was not due to a nonspecific increase in cell permeability. We also characterized the level of cross-linking in the peptidoglycan of H. influenzae cells that were grown in vitro and in vivo. The level of cross-linking was estimated as the ratio of SDS-to TCA-insoluble radioactive cell wall material after 60 min of peptidoglycan synthesis after in vivo or in vitro cultivation in the presence of [14C]alanine (Fig. 5) . The extent of peptidoglycan cross-linking was significantly reduced in cells that were cultivated in rats (P < 0.05), with a ratio of SDS-to TCA-insoluble radioactive cell wall material of 0.40, compared with a ratio of 0.86 for cells cultivated in vitro. Effects of antibiotics. We also studied the efficacy of P-lactam drugs against H. influenzae cells grown in animals because of the important changes observed in peptidoglycan crease in the radiolabeling of PBPs 3A and 3B, similar to that found in H. influenzae grown in rats, but did not seem to show alterations in the radiolabeling of PBPs 4 and 6. The amount of unlabeled 3-lactam required to block the binding of "2I-penicillin in competition assays, as measured by densitometry, revealed that although the 1"I-penicillin-binding ability of PBPs 3A, 3B, 4, and 6 was reduced in in vivo-grown cells, these PBPs-maintained the same relative affinity for ampicillin or moxalactam as that observed for PBPs in in vitro-grown cells (Fig. 8) . It was also observed that the common high-affinity PBP targets of moxalactam and ampicillin were PBPs 3A and 3B (Fig. 8) , while PBPs 1A and 5 and PBPs 1A and 2 were distinct and low-affinity targets for ampicillin and moxalactam, respectively (Fig. 9 ). Inhibitory and bactericidal activities of g1-lactams. The inhibitory and bactericidal activities of ampicillin and moxalactam were also evaluated. Bacteria collected from rats were used to inoculate antibiotic-containing sBHI, and the absorbances of the cultures were monitored with the MS-2 research system. Even at up to 40 times the antibiotic MICs, the 3-lactams had a delayed inhibitory effect on cells grown in rats (Fig. 10) rat peritoneal fluid recovered from diffusion chambers as the growth medium. Killing by ampicillin or moxalactam was equally good for cells exposed to the antibiotic in sBHI or in peritoneal fluid (Fig. 11) . Cultivation of cells in peritoneal fluid in vitro caused the same alteration in PBP profiles as that observed with cultivation in rats (data not shown). higher level of binding of 125I-penicillin to the PBPs identified as the low-affinity targets (Fig. 9 ). These observations indicated the efficient targetting and occupation of the PBP binding sites by the unlabeled 3-lactams in the treated rats in vivo. Electron microscopy also revealed some effects of the antibiotics on cell morphology (bacterial elongation and asymmetric budding) and showed that rat macrophages were observed only in diffusion chambers of treated animals (Fig.  13 ). These observations also indicate the relative efficacy and destructive ability of P-lactam antibiotics against bacteria grown in vivo.
Spontaneous resistance or tolerance to 1-lactams. Finally, the frequencies of spontaneous resistance or tolerance to ampicillin and moxalactam were also evaluated (see Materials and Methods). There was no difference in the frequencies of resistant or tolerant isolates whether bacteria were cultivated in vivo or in vitro prior to the selection of clones by antibiotic pressure. These results suggest that the changes observed in peptidoglycan metabolism and in the PBPs of cells grown in animals were apparently transient and did not efficiently predispose cells to resistance or tolerance.
DISCUSSION
The system used in the present study to measure the rate of peptidoglycan synthesis in bacteria was used by other investigators (1, 16) . Although we recognize its lower specificity compared with those of labeling systems using radioactive diaminopimelic acid as the precursor of cell wall peptidoglycan (24, 32) , we were able to show satisfactory specificity under our experimental conditions (Fig. 1, 2, and   4 ). This relatively good specificity was sufficient to reveal interesting observations on the physiological changes induced by the growth of bacteria in animals. Indeed, this study was designed to stimulate in vivo growth conditions relevant to environmental conditions found during bacterial infections in humans. Our group and other researchers have used similar diffusion chambers implanted in animals for the study of undiscovered cell properties induced by in vivo growth (8, 13, 17) . This cultivation system allows the recovery of relatively large numbers of bacteria sequestered away from host phagocytic cells and therefore suitable for various analyses. We studied some of the bacterial determinants that influence P-lactam inhibitory activity.
The rate of peptidoglycan synthesis measured in M-IV medium was apparently markedly increased in H. influenzae cells grown in rats, as seen by the higher incorporation of
[14C]alanine into cell wall material (Fig. 3 ). This observation may represent an increased growth rate in vivo or may indicate that the shift in nutrients from peritoneal fluid to M-IV medium (in which the peptidoglycan assay was performed) for in vivo-grown cells was less of a shock than the shift in nutrients from sBHI to M-IV medium for in vitrogrown cells. Alternatively, since in vivo growth rates have universally always been slower, as in the case of H. influenzae in diffusion chambers (7) , the apparent increase in the rate of peptidoglycan synthesis may represent a reduced D-alanine carboxypeptidase or transpeptidase activity in in vivo-grown bacteria that was translated to an increase in ["4CJalanine incorporation into peptidoglycan. In addition, reduced transpeptidase activity is also suggested because the extent of peptidoglycan cross-linking was significantly reduced in cells that were cultivated in rats (Fig. 5) . Furthermore, analyses of PBP profiles revealed a striking decrease in '"I-penicillin binding in cells grown in animals (Fig. 7 ).
All these observations may reflect a reduced physiological activity of PBPs and may explain the changes seen in the overall peptidoglycan metabolism of bacteria that were first cultivated in diffusion chambers. Also of interest is the apparent increase in the rate of peptidoglycan synthesis similarly provoked by the presence of moxalactam (Fig. 6) . We have no explanation for this result, but since moxalactam targets PBP 5 in addition to the same PBPs as those impaired in bacteria cultivated in rats ( Fig. 7 and 9) , we speculate that, as in E. coli, PBP 5 may have a D-alanine carboxypeptidase activity that can be additionally and specifically inhibited or reduced by moxalactam.
The striking reduction in the "I-penicillin binding activity of PBPs 3A, 3B, 4, and 6 in bacteria that were cultivated in rats (Fig. 7) may reflect a change in the physiological activity of these PBPs, which in turn may have important consequences for the inhibitory activity of 3-lactam antibiotics. A recent review outlines some growth conditions or physiological states of cells that may impair antibiotic action (9) . We have observed delayed inhibitory activity of ampicillin and moxalactam against diffusion chamber-grown cells (Fig. 10) . This observation may, however, simply reflect the nutritional shift adjustment from peritoneal fluid to sBHI and was not translated to decreased bactericidal activity when bacteria were directly exposed to P-lactams in rat peritoneal fluid (Fig. 11) . These (Fig. 13) . A very interesting observation was the resemblance between the modified PBP profile obtained for bacteria grown in vivo and that obtained for some clinically derived ampicillin-resistant transformants (Fig. 7) . Although these bacteria showed similar PBP phenotypes, we showed that the P-lactam affinity for PBPs from in vivo-grown cells was identical to that for PBPs from cells grown in test tubes (Fig.  8) , whereas the affinity of 1-lactams for the altered PBPs of resistant strains was greatly diminished (5, 23) . It (4) . One may speculate, however, that these physiological changes perhaps trigger the development of resistance. Under our experimental conditions, the frequencies of spontaneous resistance to or tolerance of I-lactam antibiotics did not increase after the exposure of bacteria to an in vivo environment. Other experiments with, for example, longer incubation periods in rats, may be necessary to rule out this interesting speculation. We recently hypothesized, on the basis of genetic and physiological studies (19, 20) and because of the ubiquity of this same resistant phenotype among clinical strains (5, 21, 22, 27) , that a mutation affecting physiological control may be the origin of multiple PBP alterations in resistant H. influenzae strains.
The study of the physiological properties of bacteria grown in a system that stimulates an environment similar to that found during infections in humans should be encouraged for predicting susceptibility to antibiotics, as indicated in a review by Lorian (15) , especially in view of the important cellular modifications in peptidoglycan metabolism reported in the present study. A search for 3-lactams that will rapidly kill bacteria in vivo is necessary to prevent consequences of delayed antibiotic action. For example, 13-lactams with a high affinity for low-molecular-mass PBP 7 in E. coli were found to be more potent for lysing nongrowing bacteria (33) .
Incidentally, we recently incriminated a similar PBP in the reduced susceptibility of E. coli to ceftazidime, a phenomenon resulting from abnormal growth conditions induced in vitro (18) . Rat intraperitoneal diffusion chambers may be of value for the study of relevant H. influenzae cell properties that influence the inhibitory activity of 3-lactams and for providing a rationale for future drug development.
